1/27
05:12 am
azn
AstraZeneca (NASDAQ:AZN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Low
Report
AstraZeneca (NASDAQ:AZN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
1/27
04:29 am
azn
AstraZeneca initiated with a Buy at Citi
Low
Report
AstraZeneca initiated with a Buy at Citi
1/6
02:14 pm
azn
AstraZeneca (NASDAQ:AZN) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
AstraZeneca (NASDAQ:AZN) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
12/10
07:21 am
azn
AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at HSBC Holdings plc.
Low
Report
AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at HSBC Holdings plc.
12/3
08:44 am
azn
AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/3
08:44 am
azn
AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
AstraZeneca (NASDAQ:AZN) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/3
07:19 am
azn
AstraZeneca (NASDAQ:AZN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
AstraZeneca (NASDAQ:AZN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/3
07:19 am
azn
AstraZeneca (NASDAQ:AZN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
AstraZeneca (NASDAQ:AZN) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.